CEP55 contributes to human gastric carcinoma by regulating cell proliferation

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4389-4399

  Tao, Jinqiu ^a   Zhi, Xiaofei ^a   Tian, Yuan ^a   Li, Zheng ^a   Zhu, Yi ^a   Wang, Weizhi ^a   Xie, Kunling ^a   Tang, Jie ^a   Zhang, Xiaoyu ^a   Wang, Linjun ^a   Xu, Zekuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; CEP55; Gastric cancer; PI3K AKT p21; Proliferation

Indexed keywords

CENTROSOMAL PROTEIN 55; CYCLIN A; CYCLIN B1; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CEP55 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; UPREGULATION; AGED; ANIMAL; CELL CYCLE CHECKPOINT; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; ANIMALS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84902956508     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1578-1     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. doi:10.3322/caac.20107.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. doi:10.1002/ijc.25516.
3. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477-90. doi:10.1016/S0140-6736(09)60617-6.
4. Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87(4):1048-54. doi:10.1016/j.athoracsur.2008.12.060. discussion 54-5.
5. Jiang B, Li Z, Zhang W, Wang H, Zhi X, Feng J, et al. miR-874 inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. J Gastroenterol. 2013. doi:10.1007/s00535-013-0851-9.
6. Fabbro M, Zhou B-B, Takahashi M, Sarcevic B, Lal P, Graham ME, et al. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 2005;9(4):477-88. doi:10.1016/j.devcel.2005.09.003. (Pubitemid 41430731)
7. Zhao WM, Seki A, Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol Biol Cell. 2006;17(9):3881-96. doi:10.1091/mbc.E06-01-0015. (Pubitemid 44330873)
8. Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, et al. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene. 2007;26(29):4272-83. doi:10.1038/sj.onc.1210207. (Pubitemid 46975797)
9. Martinez-Garay I, Rustom A, Gerdes HH, Kutsche K. The novel centrosomal associated protein CEP55 is present in the spindle midzone and the midbody. Genomics. 2006;87(2):243-53. doi:10.1016/j.ygeno.2005.11.006. (Pubitemid 43117445)
10. Sakai M, Shimokawa T, Kobayashi T, Matsushima S, Yamada Y, Nakamura Y, et al. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene. 2005. doi:10.1038/sj.onc.1209051.
11. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, et al. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene. 2009;28(30):2723-37. doi:10.1038/onc.2009. 128.
12. Blagosklonny MV, Chen C-H, Lai J-M, Chou T-Y, Chen C-Y, Su L-J, et al. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS ONE. 2009;4(4):e5052. doi:10.1371/journal.pone. 0005052.
13. Chang Y-C, Chen Y-J, Wu C-H, Wu Y-C, Yen T-C, Ouyang P. Characterization of centrosomal proteins Cep55 and pericentrin in intercellular bridges of mouse testes. Journal of Cellular Biochemistry. 2010:n/a-n/a. doi:10.1002/jcb.22517.
14. Brazil DP, Park J, Hemmings BA. PKB binding proteins. Getting in on the Akt. Cell. 2002;111(3):293-303. (Pubitemid 35341386)
15. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002;13(10):444-51. (Pubitemid 36733939)
16. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2003;2(4):339-45.
17. Testa JR, Tsichlis PN. AKT signaling in normal and malignant cells. Oncogene. 2005;24(50):7391-3. doi:10.1038/sj.onc.1209100. (Pubitemid 41637978)
18. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005;24(50):7455-64. doi:10.1038/sj.onc.1209085.
19. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400-14. doi:10.1038/nrc2657.
20. Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science. 1996;274(5293):1664-72. (Pubitemid 26414889)
21. Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672-7.
22. Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst. 1995;87(20):1499-501.
23. Delattre M. The arithmetic of centrosome biogenesis. J Cell Sci. 2004;117(9):1619-30. doi:10.1242/jcs.01128.
24. Srsen V. Merdes A. Cell Div. 2006;1(1):26. doi:10.1186/1747-1028-1-26.
25. Sankaran S, Parvin JD. Centrosome function in normal and tumor cells. J Cell Biochem. 2006;99(5):1240-50. doi:10.1002/jcb.21003.
26. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655-7. doi:10.1126/science.296.5573.1655. (Pubitemid 34579158)
27. Markman B, Atzori F, Perez-Garcia J, Tabernero J, Baselga J. Status of PI3K inhibition and biomarker development in cancer therapeutics. Ann Oncol. 2010;21(4):683-91. doi:10.1093/annonc/mdp347.
28. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. doi:10.1016/S0092-8674(00)81683-9. (Pubitemid 30046295)
29. Chen YL, Law PY, Loh HH. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Res. 2004;64(23):8723-30. doi:10.1158/0008-5472.CAN-03-3091. (Pubitemid 39552089)
30. Xu X, Sakon M, Nagano H, Hiraoka N, Yamamoto H, Hayashi N, et al. Akt2 expression correlates with prognosis of human hepatocellular carcinoma. Oncol Rep. 2004;11(1):25-32.
31. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer. 2005;103(2):307-12. doi:10.1002/cncr. 20774. (Pubitemid 40129290)
32. Yohn NL, Bingaman CN, DuMont AL, Yoo LI. Phosphatidylinositol 3′-kinase, mTOR, and glycogen synthase kinase-3β mediated regulation of p21 in human urothelial carcinoma cells. BMC Urol. 2011;11(1):19. doi:10.1186/1471-2490-11-19.
33. Lin HP, Jiang SS, Chuu CP. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. PLoS One. 2012;7(2):e31286. doi:10.1371/journal.pone.0031286.
34. Mullany LK, Nelsen CJ, Hanse EA, Goggin MM, Anttila CK, Peterson M, et al. Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J Biol Chem. 2007;282(29):21244-52. doi:10.1074/jbc.M702110200. (Pubitemid 47099959)
35. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, et al. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol. 2005;289(4):G696-703. doi:10.1152/ajpgi.00575.2004. (Pubitemid 41377176)
36. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 1998;391(6667):597-601. doi:10.1038/35404. (Pubitemid 28157603)
37. Alt JR, Gladden AB, Diehl JA. p21(Cip1) promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem. 2002;277(10):8517-23. doi:10.1074/jbc.M108867200. (Pubitemid 34968314)
38. Lin J, Reichner C, Wu X, Levine AJ. Analysis of wild-type and mutant p21WAF-1 gene activities. Mol Cell Biol. 1996;16(4):1786-93.
39. Nakanishi M, Robetorye RS, Adami GR, Pereira-Smith OM, Smith JR. Identification of the active region of the DNAsynthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 1995;14(3):555-63.